health costs

A federal disclosure rule is offering new insight on the effect of healthcare monopolies on pricing, following a wave of U.S. mergers.

A bug bite ultimately sent a North Carolina woman to the emergency room, where she had a couple of brief chats with a doctor and a dose of medicine. Now she questions why the charges were so high.

With high demand for mental health care, a wave of artificial intelligence-powered chatbots are being marketed as therapy apps — with little evidence they work and few regulations.

A kindergartner's insurer granted approval for her to see a specialist nearby, yet her parents were confused when they still owed more than $13,000. Then her uncle, a former state senator, reached out to a colleague.

Health insurance generally doesn’t cover treatment for injuries sustained shortly before a customer buys a policy. A Massachusetts woman found that out the hard way.

The regulations, proposed in June, ban credit agencies from including medical debts on consumers’ credit reports and prohibit lenders from considering medical information in assessing borrowers.

Those surveyed say the shooter has “a great deal” or “a moderate amount” of responsibility for the Dec. 4 shooting of Brian Thompson. Still, some see the suspect as a heroic figure.

Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development nor their therapeutic value, research shows.

The Jane and Daniel Och Family Foundation donated to RIP Medical Debt, a nonprofit that buys unpaid hospital bills in bulk at a reduced rate and pays them off.

With little or no income, disability applicants are seeking Social Security early retirement benefits even though it could cost them tens of thousands of dollars in future income, lawyers say.

Designed to prevent doctors from deploying expensive, ineffectual procedures, preauthorization has morphed into a monster that denies or delays care, burdens physicians with paperwork and perpetuates racial disparities.

The billionaire entrepreneur, Dallas Mavericks owner and "Shark Tank" star is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.